The cynic in me wouldn’t be surprised if all or part of this investment didn’t eventuate in the interests of propping up their FY21 EBITDA result.
“Appen intends to increase investment in Quadrant’s product and market expansion for the remainder of 2021 and in 2022 to further accelerate growth and expects this will reduce Appen’s FY21 underlying EBITDA by approximately US$2 million.”
MACQUARIE downgrades APX to Underperform from Neutral, page-174
Add APX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.0¢ |
Change
-0.015(3.03%) |
Mkt cap ! $106.7M | |||
| Open | High | Low | Value | Volume |
| 49.5¢ | 50.0¢ | 47.0¢ | $852.2K | 1.778M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 208388 | 47.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.0¢ | 60955 | 5 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
47.8¢ |
Change
-0.015 ( 4.39 %) |
||||
| Open | High | Low | Volume | ||
| 49.0¢ | 49.0¢ | 46.5¢ | 578461 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| APX (ASX) Chart |